Dermatology · Hartford, CT
NPI
1497160535
Since 2014
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
85 Seymour St Ste 700
Hartford, CT, 06106
Phone (860) 696-3350
Groups this clinician bills Medicare through
Medicare paid, 2024
$114K
1,839 services
Medicare patients, 2024
453
Average age 73
Drug cost, 2024
$3.9M
3,181 prescriptions
Company payments, 2025
$2,830
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dean D George was code 17003 (destruction skin lesion), 536 times for 115 patients. In total Dean D George billed 1,839 services in 39 codes, and Medicare paid $114K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 536 | 115 | $5.59 | $2,997 |
| 99214 Office E&M - Established | Office | 373 | 243 | $98.67 | $37K |
| 17000 Destruction Skin Lesion | Office | 221 | 168 | $46.48 | $10K |
| 99213 Office E&M - Established | Office | 182 | 147 | $71.55 | $13K |
| 17110 Destruction Skin Lesion | Office | 144 | 121 | $91.66 | $13K |
| 99203 Office E&M - New | Office | 123 | 123 | $83.10 | $10K |
| 11102 Skin Biopsy | Office | 43 | 41 | $75.45 | $3,245 |
| 17262 Destruction Skin Lesion | Office | 20 | 17 | $139.39 | $2,788 |
| 11200 Removal or Shaving of Skin Growth | Office | 14 | 13 | $62.14 | $870 |
By year: 2022 $110K for 1,712 services; 2023 $121K for 1,806 services; 2024 $114K for 1,839 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dean D George prescribed most often to Medicare patients was Ketoconazole, with 531 prescriptions and refills. In total Dean D George wrote 3,181 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 531 | 567 | 260 | $7,999 |
| Triamcinolone Acetonide Generic | 326 | 341 | 207 | $3,078 |
| Mupirocin Generic | 294 | 297 | 178 | $2,284 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 209 | 215 | 108 | $9,950 |
| Terbinafine Hcl Generic | 189 | 434 | 93 | $1,340 |
| Dupixent Pen Dupilumab | 179 | 185 | 26 | $734K |
| Ciclopirox Generic | 99 | 103 | 59 | $2,792 |
| Finasteride Generic | 98 | 248 | 26 | $646 |
| Doxycycline Monohydrate Generic | 85 | 93 | 59 | $2,535 |
| Tacrolimus Generic | 75 | 94 | 38 | $17K |
| Tretinoin Generic | 73 | 83 | 25 | $5,339 |
| Clindamycin Phosphate Generic | 72 | 73 | 27 | $1,811 |
| Skyrizi Pen Risankizumab-Rzaa | 69 | 177 | 23 | $1.4M |
| Spironolactone Generic | 68 | 166 | 16 | $443 |
| Fluconazole Generic | 56 | 103 | 38 | $337 |
Brand drugs: 637 claims; generic drugs: 2,544 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dean D George $2,830 ($2,830 in general payments such as food, travel and fees) from 15 companies. The largest payer was UCB, Inc. with $636.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 23 | $636 |
| Abbvie Inc. ABBV | 21 | $554 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $371 |
| Incyte Corporation INCY | 12 | $261 |
| Lilly USA, LLC LLY | 3 | $179 |
| Amgen Inc. AMGN | 7 | $169 |
| Genzyme Corporation SNY | 8 | $163 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $125 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $91.76 |
| Galderma Laboratories, L.P. GALD.SW | 4 | $81.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.